ArticleBritish journal of haematology2026
Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study.
Yoann Zelmat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.